Log in to save to my catalogue

Effects of hepatic fibrosis on the quantification of hepatic steatosis using the controlled attenuat...

Effects of hepatic fibrosis on the quantification of hepatic steatosis using the controlled attenuat...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11717679

Effects of hepatic fibrosis on the quantification of hepatic steatosis using the controlled attenuation parameter in patients with chronic hepatitis B

About this item

Full title

Effects of hepatic fibrosis on the quantification of hepatic steatosis using the controlled attenuation parameter in patients with chronic hepatitis B

Publisher

Korea (South): Korean Society of Ultrasound in Medicine

Journal title

Ultrasonography (Seoul, Korea), 2025-01, Vol.44 (1), p.83-91

Language

English

Formats

Publication information

Publisher

Korea (South): Korean Society of Ultrasound in Medicine

More information

Scope and Contents

Contents

This study assessed the impact of hepatic fibrosis on the diagnostic performance of the controlled attenuation parameter (CAP) in quantifying hepatic steatosis in patients with chronic hepatitis B (CHB).
CHB patients who underwent liver stiffness measurement (LSM) and CAP assessment using transient elastography before liver resection between 201...

Alternative Titles

Full title

Effects of hepatic fibrosis on the quantification of hepatic steatosis using the controlled attenuation parameter in patients with chronic hepatitis B

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11717679

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11717679

Other Identifiers

ISSN

2288-5919

E-ISSN

2288-5943

DOI

10.14366/usg.24138

How to access this item